Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Six Monthly Return

2 Jun 2015 17:10

RNS Number : 0061P
Premier Veterinary Group PLC
02 June 2015
 



 

Premier Veterinary Group plc

 

2 June 2015

 

BLOCKLISTING SIX MONTHLY RETURN

 

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

2,271,252

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

939,433

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

683,200

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no awards outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

1,000,000

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

+44(0)117 970 4127

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLREAKKAEENSEFF
Date   Source Headline
6th Sep 20134:40 pmRNSSecond Price Monitoring Extn
6th Sep 20134:35 pmRNSPrice Monitoring Extension
6th Sep 201312:54 pmRNSHolding(s) in Company
4th Sep 20134:40 pmRNSSecond Price Monitoring Extn
4th Sep 20134:35 pmRNSPrice Monitoring Extension
2nd Sep 201312:00 pmRNSHolding(s) in Company
29th Aug 20134:41 pmRNSSecond Price Monitoring Extn
29th Aug 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20139:00 amRNSHalf Yearly Report
16th Aug 20134:40 pmRNSSecond Price Monitoring Extn
16th Aug 20134:35 pmRNSPrice Monitoring Extension
15th Aug 20135:32 pmRNSHolding(s) in Company
14th Aug 20134:56 pmRNSHolding(s) in Company
30th Jul 20134:40 pmRNSSecond Price Monitoring Extn
30th Jul 20134:35 pmRNSPrice Monitoring Extension
23rd Jul 20133:44 pmRNSHolding(s) in Company
9th Jul 20132:00 pmRNSCompany Update
8th Jul 20134:40 pmRNSSecond Price Monitoring Extn
8th Jul 20134:35 pmRNSPrice Monitoring Extension
5th Jul 201310:48 amRNSHolding(s) in Company
5th Jul 20137:00 amRNSCompany Update
27th Jun 20134:40 pmRNSSecond Price Monitoring Extn
27th Jun 20134:35 pmRNSPrice Monitoring Extension
25th Jun 20132:05 pmRNSResults of Annual General Meeting
14th Jun 20134:40 pmRNSSecond Price Monitoring Extn
14th Jun 20134:35 pmRNSPrice Monitoring Extension
4th Jun 20132:48 pmRNSBlocklisting Six Monthly Return
24th May 20134:40 pmRNSSecond Price Monitoring Extn
24th May 20134:35 pmRNSPrice Monitoring Extension
17th May 20137:00 amRNSInterim Management Statement
16th May 20131:20 pmRNSHolding(s) in Company
8th May 20136:09 pmRNSHolding(s) in Company
8th May 20135:47 pmRNSHolding(s) in Company
2nd May 20131:45 pmRNSHolding(s) in Company
1st May 20134:35 pmRNSPrice Monitoring Extension
30th Apr 20137:00 amRNSFinal Results
26th Apr 20134:50 pmRNSHolding(s) in Company
24th Apr 20133:47 pmRNSHolding(s) in Company
26th Mar 20134:40 pmRNSSecond Price Monitoring Extn
26th Mar 20134:35 pmRNSPrice Monitoring Extension
22nd Mar 201311:50 amRNSHolding(s) in Company
20th Mar 20131:15 pmRNSHolding(s) in Company
19th Mar 201311:34 amRNSForm 8.3 - Ark Therapeutics
19th Mar 20139:47 amRNSHolding(s) in Company
18th Mar 20131:54 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Mar 201312:01 pmRNSTermination of Offer Period and Rule 10.8 Waiver
7th Mar 20134:22 pmRNSForm 8.3 - [Ark Therapeutics Group]
6th Mar 20133:04 pmRNSForm 8.3 - [Ark Therapeutics Group]
6th Mar 201310:02 amRNSForm 8.3 - Ark Therapeutics Group Plc
1st Mar 201311:49 amRNSForm 8.3 - Ark Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.